Emry Lloyd

Frederick Schnell, MD, Nicolas Ferreyros, and Barbara McAneny, MD, discuss health care advocacy and policy at CPC & CBEx 2023

News

How Congress Plans to Address Patient and Hospital Challenges, and How This Could Affect Oncologists

10/10/2023

At CPC & CBEx 2023, Barbara McAneny, MD, Nicolas Ferreyros, and Frederick Schnell, MD, shared insight into Congress’s plan to address specific patient and hospital concerns, and how it might affect oncologists.

At CPC & CBEx 2023, Barbara...

10/10/2023

Journal of Clinical Pathways

News

A Deeper Look Into Hypertension and Cardiovascular Toxicity Symptoms for Patients Treated With Ibrutinib

10/13/2023

Emry Lloyd ;

Max Gordon, MD, and colleagues evaluated the long-term effects in patients with chronic lymphocytic leukemia who reported hypertension or cardiovascular issues while receiving ibrutinib.

Max Gordon, MD, and colleagues...

10/13/2023

Journal of Clinical Pathways

News

Researchers Identify Common Treatment Patterns for Patients With Parkinson Disease

12/21/2023

Emry Lloyd ;

In a recent study, Richard Houghton from Product Development Personalized Health Care and colleagues investigated the treatment patterns found in patients with Parkinson disease using data found from insurance claims.

In a recent study, Richard...

12/21/2023

Annals of Long-Term Care

Conference Coverage

Research Shows that Health Care Costs Vary Based on HIC Status in Patients With NSCLC

06/13/2023

Emry Lloyd ;

In an abstract presented at ASCO 2023, researchers compared real-world data on health care costs for HIC-H and HIC-C patients with NSCLC before and after they received the HIC test.

In an abstract presented at ASCO...

06/13/2023

Journal of Clinical Pathways

Conference Coverage

The Influence of End-of-Life Care Costs on Episodic Value-Based Care Models

11/02/2023

Emry Lloyd ;

In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.

In this study, Gunjan Sharma,...

11/02/2023

Pharmacy Learning Network

Evaluation of Efficacy and Safety of Momelotinib for Patients With Myelofibrosis and Thrombocytopenia

11/17/2023

Emry Lloyd ;

Researchers recently studied the safety and efficacy of momelotinib for patients with myelofibrosis and thrombocytopenia using data from 3 key clinical trials.

Researchers recently studied the...

11/17/2023

Journal of Clinical Pathways

News

Does Mode of Meal Delivery Contribute to Nursing Home Admissions?

12/27/2023

Emry Lloyd ;

Kali S. Thomas and colleagues investigated whether older adults living with dementia who receive frozen meals have higher rates of nursing home admissions compared to those receiving daily delivered meals.

Kali S. Thomas and colleagues...

12/27/2023

Annals of Long-Term Care

Conference Coverage

Study Examines Real-World Outcomes of Novel Treatments for Diffuse Large B-Cell Lymphoma

06/14/2023

Emry Lloyd ;

Researchers conducted a retrospective analysis to evaluate the outcomes of patients with R/R DLBCL treated with novel therapies, with a subanalysis of patients who received CAR T prior to novel therapies.

Researchers conducted a...

06/14/2023

Journal of Clinical Pathways

Conference Coverage

How Well Does the Enhancing Oncology Model Capture Treatment Costs in Disease Groups?

10/30/2023

Emry Lloyd ;

Katherine Baker, MD, and colleagues investigated how the Enhancing Oncology Model captures the performance risk and treatment costs within a disease.

Katherine Baker, MD, and...

10/30/2023

Pharmacy Learning Network

News

Real-World Evidence Study Reveals Improved Survival in Biliary Tract Cancer Through Molecular Targeted Treatments

11/17/2023

Emry Lloyd ;

The use of molecular profiling for targeted treatments has shown a significant improvement in survival outcomes for patients with biliary tract cancer, according to a new study based on real-world evidence.

The use of molecular profiling...

11/17/2023

Journal of Clinical Pathways